Immunovant Statistics
NASDAQ: IMVTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
32.04-0.07 (-0.22%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Immunovant by the numbers
Immunovant has a market capitalization of $6.62 billion based on 206.55M shares outstanding. With trailing EPS of $-2.81, Immunovant is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.6% below its 50-day average and 0.8% above its 200-day average.
Average daily trading volume is 1.23M shares, or about $39.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMVT valuation vs. peer median
| Metric | IMVT | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.62B | $5.43B | +22% |
| Avg. volume | 1.23M | 1.99M | -38% |
Peer median across 8 companies: IOVA, KOD, SRRK, CRSP, KYMR, ADPT, QGEN, RLAY.
Valuation
- Market cap
- $6.62B
- EPS (TTM)
- $-2.81
- Shares outstanding
- 206.55M
Price and trading
- Previous close
- 32.11
- Open
- 31.72
- Day range
- 31.58 – 32.75
- 52-week range
- 16.08 – 45.42
- 52-week change
- +98.88%
- Beta
- —
- Volume
- 1.13M
- Average volume
- 1.23M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 6.62B
- Forward Pe
- -11.65
- Eps
- -2.81
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 45.42
- Week52 Low
- 16.08
- Avg Volume
- 1.23M
- Shares Outstanding
- 206.55M
- Ma50
- 38.89
- Ma200
- 31.80
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -29.46%
- Pct From52w Low
- 99.25%